Holy Cross Germantown Hospital provides expert care for complicated pregnancies like Desma's.
Read Her STORY
Patient has a confirmed diagnosis of a select solid tumor (except with a primary diagnosis of ALK+ NSCLC) or hematologic malignancy and is in need of treatment because of progression or relapse
Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module 7 – Ceritinib (LDK378) for patients whose tumors have aberrations in ALK or ROS1
Holy Cross Hospital: 301-754-7000 | Holy Cross Germantown Hospital: 301-557-6000
© 2016 Holy Cross Health
Holy Cross Hospital | Holy Cross Germantown Hospital